XML 44 R25.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Shares | 12 Months Ended
--- | ---
Dec. 31, 2018
Equity [Abstract] |
Shares | Shares a) Common shares Issued and outstanding:
|  | Common shares |  |  | Treasury shares |  |  | Common shares outstanding, net of treasury shares |
Issued and outstanding at December 31, 2016 |  | 30,518,907 |  |  | (2,213,247 | ) |  | 28,305,660 |
Issued upon exercise of stock options |  | 176,800 |  |  | — |  |  | 176,800 |
Purchase of treasury shares for settlement of certain equity classified stock-based compensation |  | — |  |  | (758,271 | ) |  | (758,271 | )
Settlement of certain equity classified stock-based compensation |  | — |  |  | 353,592 |  |  | 353,592 |
Retired through share purchase program |  | (2,625,557 | ) |  | — |  |  | (2,625,557 | )
Issued and outstanding at December 31, 2017 |  | 28,070,150 |  |  | (2,617,926 | ) |  | 25,452,224 |
Issued upon exercise of stock options |  | 297,940 |  |  | — |  |  | 297,940 |
Issued upon conversion of convertible debentures |  | 2,211 |  |  | — |  |  | 2,211 |
Purchase of treasury shares for settlement of certain equity classified stock-based compensation |  | — |  |  | (660,620 | ) |  | (660,620 | )
Settlement of certain equity classified stock-based compensation |  | — |  |  | 1,193,935 |  |  | 1,193,935 |
Retired through share purchase program |  | (1,281,485 | ) |  | — |  |  | (1,281,485 | )
Issued and outstanding at December 31, 2018 |  | 27,088,816 |  |  | (2,084,611 | ) |  | 25,004,205 |
Upon settlement of certain equity classified stock-based compensation during the year ended December 31, 2018, the Company repurchased 553,036 shares at $4,308 to satisfy the recipient tax withholding requirements (year ended December 31, 2017 - 161,285 shares at $987). The repurchased shares are included in the purchase of treasury shares for settlement of certain equity classified stock-based compensation. b) Net income per share For the year ended December 31, 2018, there were 14,247 stock options that were anti-dilutive and therefore not considered in computing diluted earnings per share (year ended December 31, 2017 – 469,819 stock options and 2,949,309 shares issuable on conversion of Convertible Debentures).
Year ended December 31, | 2018 |  |  | 2017 |
Net income available to common shareholders | $ | 15,286 |  |  | $ | 5,264 |
Interest from Convertible Debentures (after tax) | 1,792 |  |  | — |
Diluted net income available to common shareholders | $ | 17,078 |  |  | $ | 5,264 |
Weighted average number of common shares | 24,991,517 |  |  | 26,697,066 |
Weighted average effect of dilutive securities |  |  |
Dilutive effect of treasury shares | 2,394,824 |  |  | 2,622,957 |
Dilutive effect of stock options | 357,026 |  |  | 285,703 |
Dilutive effect of Convertible Debentures | 3,684,424 |  |  | — |
Weighted average number of diluted common shares | 31,427,791 |  |  | 29,605,726 |
Basic net income per share | $ | 0.61 |  |  | $ | 0.20 |
Diluted net income per share | $ | 0.54 |  |  | $ | 0.18 |
c) Share purchase programs On August 9, 2016, the Company commenced a normal course issuer bid ("NCIB") which was subsequently amended in 2017 to purchase a maximum of 2,733,482 shares. During the year ended December 31, 2017, the maximum number of shares to be purchased was 1,657,514 of which 1,482,795 were purchased, resulting in a reduction to common shares of $12,763 and an increase to additional paid-in capital of $3,484. Commencing on August 14, 2017, the Company engaged in a NCIB under which a maximum number of 2,424,333 common shares were authorized to be purchased. As at December 31, 2017, 1,142,762 shares had been purchased and subsequently cancelled under this NCIB, resulting in a reduction of common shares of $9,810 and an increase to additional paid-in capital of $4,119. During the twelve months ended December 31, 2018, the Company purchased and subsequently cancelled a further 1,281,485 shares, which resulted in a reduction of common shares of $10,975 and an increase to additional paid-in capital of $1,435. This NCIB expired on August 13, 2018. d) Dividends The Company intends to pay an annual aggregate dividend of eight Canadian cents ($0.08) per common share, payable on a quarterly basis. During the year ended December 31, 2018, the Company paid regular quarterly cash dividends of $0.02 per share on common shares (December 31, 2017 - $0.02). At December 31, 2018, an amount of $500 was included in accrued liabilities related to the dividend declared on October 29, 2018 (December 31, 2017 - $510).

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration